{"mainPropery":{"diseaseId":3103,"diseaseName":"Punctate palmoplantar keratoderma type I","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/3103/punctate-palmoplantar-keratoderma-type-i","synonyms":["Brauer-Buschke-Fischer syndrome","Keratodermia palmoplantaris papulosa, Buschke-Fischer-Brauer type","Type I punctate palmoplantar keratoderma","Keratoderma, palmoplantar punctate type 1","Keratosis palmoplantaris papulosa","Punctate palmoplantar keratoderma type 1"],"synonyms-with-source":[{"name":"Brauer-Buschke-Fischer syndrome","source":""},{"name":"Keratodermia palmoplantaris papulosa, Buschke-Fischer-Brauer type"},{"name":"Type I punctate palmoplantar keratoderma"},{"name":"Keratoderma, palmoplantar punctate type 1"},{"name":"Keratosis palmoplantaris papulosa","source":"OMIM"},{"name":"Punctate palmoplantar keratoderma type 1","source":""}],"identifiers":[{"identifierType":"OMIM","identifierId":"148600"},{"identifierType":"ORPHANET","identifierId":"79501"},{"identifierType":"UMLS","identifierId":"C1835662"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":376,"resourceName":"Foundation for Ichthyosis and Related Skin Types","abbreviation":"FIRST","address1":"2616 North Broad Street","address2":"","address3":"","address4":"","address5":"","city":"Colmar","state":"PA","zip":"18915 ","country":"United States","phone":"+1-215-997-9400","tty":"","tollFree":"1-800-545-3286","fax":"","email":"info@firstskinfoundation.org","url":"http://www.firstskinfoundation.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/148600' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=%28Buschke%5BAll%20Fields%5D%20AND%20fischer%5BAll%20Fields%5D%20AND%20brauer%5BAll%20Fields%5D%20AND%20%28%22syndrome%22%5BMeSH%20Terms%5D%20OR%20%22syndrome%22%5BAll%20Fields%5D%29%29%20OR%20%28Type%5BAll%20Fields%5D%20AND%20punctate%5BAll%20Fields%5D%20AND%20%28%22keratoderma%2C%20palmoplantar%22%5BMeSH%20Terms%5D%20OR%20%28%22keratoderma%22%5BAll%20Fields%5D%20AND%20%22palmoplantar%22%5BAll%20Fields%5D%29%20OR%20%22palmoplantar%20keratoderma%22%5BAll%20Fields%5D%20OR%20%28%22palmoplantar%22%5BAll%20Fields%5D%20AND%20%22keratoderma%22%5BAll%20Fields%5D%29%29%29&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Punctate palmoplantar keratoderma type I. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":111,"resourceId":972,"resourceName":"Centers for Mendelian Genomics","descriptionText":"The <a href='http://mendelian.org/' target='_blank'>Centers for Mendelian Genomics</a> program is working to discover the causes of rare genetic disorders. For more information about applying to the research study, please visit their website.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1347,"resourceId":376,"resourceName":"Foundation for Ichthyosis and Related Skin Types","descriptionText":"<a href='http://www.firstskinfoundation.org/first-research-grant-program' target='_blank'>Foundation for Ichthyosis and Related Skin Types</a>Â has funded ichthyosis-related research through its Research Grant Program.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1108406-overview#aw2aab6b5' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79501' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1539,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ResearchTrials_ResearchProjects.php?lng=EN&type_list=researchtrials_search_simple_shd&data_id=11527&disease(s)/group%20of%20diseases=Keratoderma--palmoplantar-punctate--type-I--Buschke-Fischer-Brauer-syndrome-&search=ResearchTrials_ResearchProjects_Simple&ChdId=11527&ResearchTrials_ResearchTrials_ResearchProjects_diseaseGroup=Buschke&ResearchTrials_ResearchTrials_ResearchProjects_diseaseType=Pat&ResearchTrials_ResearchTrials_ResearchProjects_country=NN&ResearchTrials_ResearchTrials_ResearchProjects_GeographicType=null' target='_blank'>Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search.php?lng=EN&type_list=clinicalLabs_search_simple_shd&data_id=11527&disease(s)/group%20of%20diseases=Keratoderma--palmoplantar-punctate--type-I--Buschke-Fischer-Brauer-syndrome-&search=ClinicalLabs_Search_Simple&ChdId=11527&ClinicalLabs_ClinicalLabs_Search_diseaseGroup=Buschke&ClinicalLabs_ClinicalLabs_Search_diseaseType=Pat&ClinicalLabs_ClinicalLabs_Search_country=NN&ClinicalLabs_ClinicalLabs_Search_GeographicType=null&ClinicalLabs_ClinicalLabs_Search_ClinicalLabsList_Sort=QoS' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='https://www.dermnetnz.org/topics/punctate-type-palmoplantar-keratoderma/' target='_blank'>DermNet New Zealand</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Punctate palmoplantar keratoderma type I. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Punctate palmoplantar keratoderma type I:<br />\r\n<a href='http://www.firstskinfoundation.org/ichthyosis-registry' target='_blank'>The National Registry for Ichthyosis & Related Skin Disorders</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":3130,"questionText":"What is punctate palmoplantar keratoderma type I?","answerText":"<strong>Punctate palmoplantar keratoderma type I</strong> is a rare condition that affects the skin. It is a sub-type of <a href=\"http://www.dermnetnz.org/scaly/punctate-keratoderma.html\" target=\"_blank\">punctate palmoplantar keratoderma</a>.[2126][2127][2129] Signs and symptoms typically begin in early adolescence or later and include hard, round bumps of thickened skin on the palms of the hands and soles of the feet. These bumps can cause pain in some people.[2126][2127][2128][2129] The condition&nbsp;is usually inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner and can be caused by a&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in the <em><a href=\"https://ghr.nlm.nih.gov/gene/AAGAB\" target=\"_blank\">AAGAB</a></em> gene.[5618] Treatment options may include removal of the thickened skin by a doctor or using a cream on the affected area. Some people have used surgical approaches consisting of excision and skin grafting.[5619]","dateModified":"2017-06-28T00:00:00"},"basicQuestions":[{"questionId":3131,"questionText":"What are the signs and symptoms of punctate palmoplantar keratoderma type 1?","answerText":"Signs and symptoms of punctate palmoplantar keratoderma type 1 tend to become evident between the ages of 10 to 30 years. Symptoms include multiple tiny, hard, round bumps of thickened skin on the palms of the hands and soles of the feet. These bumps may join to form calluses on pressure points, which may cause pain. They may also make walking difficult, or impair hand or finger movement.[2128] Symptoms tend to worsen with time and may be aggravated by manual work or injury.[2127]<br />\r\n<br />\r\nIn some families, punctate palmoplantar keratoderma type 1 appears to be associated with an increased risk for several types of cancer.[2127][2128][2129][2130] The types of cancer that may be associated with punctate palmoplantar keratoderma type I include Hodgkin disease, squamous cell carcinoma, and kidney, breast, pancreatic, and colon cancers.[2129]&nbsp;","dateModified":"2017-06-29T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":2127,"authors":"Oztas P et al.,","articleTitle":"Punctate palmoplantar keratoderma (Brauer-Buschke-Fisher Syndrome)","bookWebsiteJournalTitle":"Am J Clin Dermatol","date":"2007"},{"referenceId":2128,"authors":"Erkek E et al.,","articleTitle":"Type I Hereditary punctuate keratoderma associated with widespread lentigo simplex and successfully treated with low-dose oral acitretin","bookWebsiteJournalTitle":"Arch Dermatology","date":"2006 Aug"},{"referenceId":2129,"authors":"Asadi AK","articleTitle":"Type I hereditary punctuate keratoderma","bookWebsiteJournalTitle":"Dermatology Online Journal","date":"2003"},{"referenceId":2130,"authors":"","articleTitle":"Keratoderma, palmoplantar, punctuate type I","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man","date":"June 8, 2016","volume":"","pages":"","url":"http://omim.org/entry/148600","dateAccessed":"2016-01-01T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3133,"questionText":"What causes palmoplantar keratoderma type 1?","answerText":"In most families, punctate palmoplantar keratoderma type 1 is caused by a mutation in the <em><a href=\"https://ghr.nlm.nih.gov/gene/AAGAB\" target=\"_blank\">AAGAB</a></em>&nbsp;gene. &nbsp;The gene is thought to play an important role in skin integrity.[5620] When the gene is not working properly, the skin clumps together, forming the bumps on the skin that are characteristic of the condition.[5620]&nbsp;<br />","dateModified":"2017-06-29T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":5618,"authors":"","articleTitle":"KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE I; PPKP1","bookWebsiteJournalTitle":"OMIM","date":"November, 2014","volume":"","pages":"","url":"http://omim.org/entry/148600","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5620,"authors":"Giehl KA, et al","articleTitle":"Nonsense Mutations in AAGAB Cause Punctate Palmoplantar Keratoderma Type Buschke-Fischer-Brauer","bookWebsiteJournalTitle":"Am J Hum Genet","date":"October 5, 2012","volume":"91(4)","pages":"754-759"},{"referenceId":5622,"authors":"Patel S, Zirwas M, English JC 3rd","articleTitle":"Acquired palmoplantar keratoderma","bookWebsiteJournalTitle":"Am J Clin Dermatol","date":"2007","volume":"8(1)","pages":"1-11"}]},{"questionId":3134,"questionText":"How is punctate palmoplantar keratoderma type I inherited?","answerText":"Punctate palmoplantar keratoderma type I is usually inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>&nbsp;manner.[2126][2127][2128][2129][2130]&nbsp;<span style=\"font-size: 12pt;\">Autosomal dominant inheritance is when only one </span><a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/genemutation\" target=\"_blank\" style=\"font-size: 12pt;\">mutated</a><span style=\"font-size: 12pt;\"> copy of&nbsp;a disease-causing&nbsp;</span><a href=\"http://ghr.nlm.nih.gov/handbook/basics/gene\" target=\"_blank\" style=\"font-size: 12pt;\">gene</a><span style=\"font-size: 12pt;\"> in each cell is necessary for a person to be affected. An autosomal dominant condition may occur for the first time in an affected individual due to a new mutation, or may be inherited from an affected parent. A person with punctate keratoderma has a 50% chance of passing on the condition to each of his or her children.[453]</span>\r\n<br />\r\n<br />\r\nPunctate palmoplantar keratoderma type I also shows reduced penetrance.[13529] This means that not everyone who inherits the gene mutation that causes the condition will develop symptoms of the condition. However, this person would still be at risk of passing the disease-causing mutation to their offspring.","dateModified":"2017-06-29T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":453,"authors":"","articleTitle":"What are the different ways in which a genetic condition can be inherited?","bookWebsiteJournalTitle":"Genetics Home Reference Web site","date":"January 25, 2016","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/handbook/inheritance/inheritancepatterns","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2126,"authors":"Martinez-Mir A et al","articleTitle":"Identification of a locus for type I punctuate palmoplantar keratoderma on chromosome 15q22-q24","bookWebsiteJournalTitle":"J Med Genet","date":"2003"},{"referenceId":2127,"authors":"Oztas P et al.,","articleTitle":"Punctate palmoplantar keratoderma (Brauer-Buschke-Fisher Syndrome)","bookWebsiteJournalTitle":"Am J Clin Dermatol","date":"2007"},{"referenceId":2128,"authors":"Erkek E et al.,","articleTitle":"Type I Hereditary punctuate keratoderma associated with widespread lentigo simplex and successfully treated with low-dose oral acitretin","bookWebsiteJournalTitle":"Arch Dermatology","date":"2006 Aug"},{"referenceId":2129,"authors":"Asadi AK","articleTitle":"Type I hereditary punctuate keratoderma","bookWebsiteJournalTitle":"Dermatology Online Journal","date":"2003"},{"referenceId":2130,"authors":"","articleTitle":"Keratoderma, palmoplantar, punctuate type I","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man","date":"June 8, 2016","volume":"","pages":"","url":"http://omim.org/entry/148600","dateAccessed":"2016-01-01T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13529,"authors":"Leung KC and Barankin B","articleTitle":"Punctate Palmoplantar Keratoderma (Brauer-Buschke-Fisher Syndrome) - Report of a Case and Review of the Literature","bookWebsiteJournalTitle":"SM Journal of Case Reports","date":"2015","volume":"1(1)","pages":"1003","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3135,"questionText":"How is punctate palmoplantar keratoderma type I diagnosed?","answerText":"Diagnosis of punctate palmoplantar keratoderma type I may be established based on  a positive family history (i.e., other affected family members), the presence of the signs associated with the condition, and certain cell histology (i.e., appearance of skin samples when viewed under a microscope).[2129] The diagnosis of the condition may be confirmed with genetic testing.&nbsp;","dateModified":"2017-06-29T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":2129,"authors":"Asadi AK","articleTitle":"Type I hereditary punctuate keratoderma","bookWebsiteJournalTitle":"Dermatology Online Journal","date":"2003"}]},{"questionId":3132,"questionText":"How might punctate palmoplantar keratoderma type 1 be treated?","answerText":"Treatment options for punctate palmoplantar keratoderma type I generally include topical creams and removal of the lesions by a doctor. In some cases, oral medications may be prescribed to try to ease symptoms. These therapies can lead to temporary softening of the skin and a decrease in skin thickness.[10312] Unfortunately, in many cases, treatment does not provide consistent or long-lasting results.[5623]<br />\r\n<br />\r\nThere has been some reported success using creams that break up the <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=721317\" target=\"_blank\">keratin</a> deposits on the skin, such as <a href=\"https://www.aaaai.org/conditions-and-treatments/conditions-dictionary/inhaled-corticosteroids\" target=\"_blank\">corticosteroids</a>, urea, <a href=\"https://medlineplus.gov/druginfo/meds/a607072.html\" target=\"_blank\">salicylic acid</a>, lactic acid, or vitamin A. Systemic therapy using vitamin D analogues, aromatic retinoids, and <a href=\"https://medlineplus.gov/druginfo/meds/a605010.html\" target=\"_blank\">5-fluorouracil</a> has also been used. However, people on these medications often require chronic, low-dose therapy. These topical and systemic treatments carry a variety of side effects.[5623]<br />\r\n<br />\r\nSurgery, including excision of affected areas of the skin and replacement with unaffected skin, has been used on lesions resistant to other forms of treatment. However, healing after surgery can be difficult. Treatment with a CO<sub>2</sub> laser may be possible for limited affected areas on the palms.[5623]","dateModified":"2017-06-29T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":5623,"authors":"O'connor EA, Dzwierzynski WW","articleTitle":"Palmoplantar keratoderma: treatment with CO2 laser case report and review of the literature","bookWebsiteJournalTitle":"Ann Plast Surg","date":"October 2011","volume":"67(4)","pages":"439-441","url":"https://www.ncbi.nlm.nih.gov/pubmed/21540729","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10312,"authors":"Charny JW and James WD","articleTitle":"Keratosis Palmaris et Plantaris","bookWebsiteJournalTitle":"Medscape Reference","date":"June 10, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1108406-overview#a1","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11956,"questionText":"What is the long-term outlook for people affected by punctate palmoplantar keratoderma type I?","answerText":"Punctate palmoplantar keratoderma type I does not affect a person&rsquo;s lifespan. Many people with this condition do find that they develop more skin lesions with age.[13529]<span style=\"color: red;\"> </span>Additionally, the symptoms of punctate palmoplantar keratoderma type I and some of the treatments for the condition may have side effects that impact a person's quality of life. The long-term outlook may differ depending on each person&rsquo;s individual symptoms and pain tolerance.[13530]","dateModified":"2017-06-29T11:42:00","resourceClassificationName":"Prognosis","references":[{"referenceId":13529,"authors":"Leung KC and Barankin B","articleTitle":"Punctate Palmoplantar Keratoderma (Brauer-Buschke-Fisher Syndrome) - Report of a Case and Review of the Literature","bookWebsiteJournalTitle":"SM Journal of Case Reports","date":"2015","volume":"1(1)","pages":"1003","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13530,"authors":"Giehl K","articleTitle":"Punctate palmoplantar keratoderma type I","bookWebsiteJournalTitle":"Orphanet","date":"January 2015","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=79501","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":13529,"authors":"Leung KC and Barankin B","articleTitle":"Punctate Palmoplantar Keratoderma (Brauer-Buschke-Fisher Syndrome) - Report of a Case and Review of the Literature","bookWebsiteJournalTitle":"SM Journal of Case Reports","date":"2015","volume":"1(1)","pages":"1003","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13530,"authors":"Giehl K","articleTitle":"Punctate palmoplantar keratoderma type I","bookWebsiteJournalTitle":"Orphanet","date":"January 2015","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=79501","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10312,"authors":"Charny JW and James WD","articleTitle":"Keratosis Palmaris et Plantaris","bookWebsiteJournalTitle":"Medscape Reference","date":"June 10, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1108406-overview#a1","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":12879,"relatedDiseaseName":"Hereditary palmoplantar keratoderma","relation":"Parent","isRare":false,"hasGardPage":true},{"relatedDiseaseId":12888,"relatedDiseaseName":"Isolated punctate palmoplantar keratoderma","relation":"Parent","isRare":false,"hasGardPage":false},{"relatedDiseaseId":8167,"relatedDiseaseName":"Palmoplantar keratoderma","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":909,"phenoTypeName":"Punctate palmoplantar hyperkeratosis","frequencyText":"Obligate","percentRanges":"100%"},{"phenoTypeId":8267,"phenoTypeName":"Palmoplantar keratoderma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8875,"phenoTypeName":"Breast carcinoma","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8876,"phenoTypeName":"Colon cancer","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4891,"phenoTypeName":"Hodgkin lymphoma","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4303,"phenoTypeName":"Neoplasm of the pancreas","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15049,"phenoTypeName":"Renal cell carcinoma","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":100,"phenoTypeName":"Transitional cell carcinoma of the bladder","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4758,"phenoTypeName":"Abnormality of the nail","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":5326,"phenoTypeName":"Epidermal acanthosis","percentRanges":"-"},{"phenoTypeId":5347,"phenoTypeName":"Hypergranulosis","percentRanges":"-"},{"phenoTypeId":6255,"phenoTypeName":"Late onset","percentRanges":"-"},{"phenoTypeId":11508,"phenoTypeName":"Orthokeratosis","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Punctate_palmoplantar_keratoderma_type_I"}